A novel apparatus for the determination of solubility in pressurized metered dose inhalers

Drug Development and Industrial Pharmacy

Volumn 32, Issue 10, 2006, Pages 1159-1163

  Traini, Daniela ^a   Young, Paul M ^a   Price, Robert ^b   Rogueda, Phillipe ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Bath   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Budesonide; Formoterol fumarate dihydrate; HFA; pMDI; Salbutamol sulfate; Solubility

Indexed keywords

BUDESONIDE; FLUORINATED HYDROCARBON; FORMOTEROL FUMARATE; PROPELLANT; SALBUTAMOL SULFATE;

APPARATUS; ARTICLE; DEVICE; DRUG PACKAGING; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; METERED DOSE INHALER; PRESSURIZED METERED DOSE INHALER;

ADMINISTRATION, INHALATION; AEROSOL PROPELLANTS; ALBUTEROL; BUDESONIDE; CHEMISTRY, PHARMACEUTICAL; CHLOROFLUOROCARBONS, METHANE; EQUIPMENT DESIGN; ETHANOLAMINES; HUMANS; METERED DOSE INHALERS; PRESSURE; SOLUBILITY;

EID: 33750856241     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600920325     Document Type: Article

References (13)

1. Dalby, R. N., Phillips, E. M., & Byron, P. R. (1991). Determination of drug solubility in aerosol propellants. Pharmaceutical Research, 8, 1206-1209.
2. Dickinson, P. A., Seville, P. C., McHale, H., Perkins, N. C., & Taylor, G. (2000). An investigation of the solubility of various compounds in the hydrofluoroalkane propellants and possible model liquid propellants. Journal of Aerosol Medicine, 13, 179-186.
3. Gupta, A., & Myrdal, P. B. (2004). On-line high-performance liquid chromatography method for analyte quantitation from pressurized metered dose inhalers. Journal of Chromatography A, 1033, 101-106.
4. Gupta, A., & Myrdal, P. B. (2005). A comparison of two methods to determine the solubility of compounds in aerosol propellants. International Journal of Pharmaceutics, 292, 201-209.
5. Howlett, D., Colwell, J., Goldsmith, S., & McCallion, O. N. (2002). Correlation of extractables and leachables from marketed in pressurized inhalers formulated as solutions. Respiratory Drug Delivery VIII, I, 129-136.
6. Johnson, K. A. (1996). Interfacial phenomena and phase behaviour in metered dose inhaler formulation. In A. J. Hickey (Ed.) Inhalation aerosols: physical and biological basis for therapy (pp. 385-415). New York: Marcel Dekker, Inc.
7. Oswald, W. (1896). Lehrbruck der Allgemeinen Chemie (Vol. 2, Part 1); Leipzig, Germany.
8. Pritchard, J. N. (2001). The influence of lung deposition on clinical response. Journal of Aerosol Medicine, (14), S19-S26.
9. Rogueda, P. (2005). Novel hydrofluoroalkane suspension formulations for respiratory drug delivery. Expert Opinion on Drug Delivery, 2, 625-638.
10. Smyth, H. D. C. (2005). Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opinion on Drug Delivery, 2, 53-74.
11. Williams, R. O., III, Patel, A. M., Barron, M. K., & Rogers, T. L. (2001). Investigation of Some Commercially Available Spacer Devices for the Delivery of Glucocorticoid Steroids from a pMDI. Drug Delivery Industrial Pharmacy, 5, 401-412.
12. Williams, R. O., III, Rogers, T. L., & Liu, J. (1999). Study of solubility of steroids in hydrofluoroalkane propellants. Drug Development and Industrial Pharmacy, 25, 1227-1234.
13. Wilson, P. W. (1994). A Model for Thermal Hysteresis Utilizing the Anisotropic Interfacial Energy of Ice Crystals. Cryobiology, 31, 406-412.